… to follow Medicare, dishonestly claiming to follow Medicare on allergy immunotherapy, reimbursement, allergy shots, and completely denying care for that very life changing reimbursement for that very life changing treatment. Given the market power of United Healthcare, this will put this particular therapy out of business within, I would say, six months to a year if UHC's policy continues, you know, for 45 million UnitedHealthcare insured patients. So I think we need to, we need to watch that. Not only the barriers to care upfront, but if insurers can arbitrarily use their market power to deny reimbursement, that care will go away. (06:25–06:42)
CLAIM
Asserts that United Healthcare's policy could end allergy immunotherapy within a year for 45 million insured patients.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
